Andrew Forced To Enhance NHS Negligence Funding; Amag Q4 Sales To Miss Anticipations
Thu, 01/12/2012 - 07:50 | 
Andrew Lansley has been forced to offer up an added £185 million boost to assist the NHS fund legal battles because of growing numbers of carelessness claims.
Pain pills such as Percocet and Opana from Endo Pharmaceuticals may be in short supply after their fabrication plant was closed for production as well as quality concerns.
Ariad Pharmaceuticals’s scrip had its “outperform” ranking reaffirmed by research forecasters at Rodman & Renshaw in a report released on January 14.
Amag Pharmaceuticals stated that it anticipates its fourth quarter earnings to miss Street expectations, though it repeated its full year financial 2012 viewpoint.
Tags: Pfizer Lifts Up Dividend; Salix Pharma Crossed Bearish Moving Average
Pharma giant Pfizer declared that its directors have sanctioned a 10% dividend increase in 2012.
Endo PharmaceuticalHoldings (ENDP) pushed the Health Care division elevated on December 12, making it featured health care victor.
Salix Pharmaceuticals scrip has crossed bearishly lower their 10-day moving average of $44.11 on a volume of 283K shares.
India is seeing a stable growth in the number of diabetes and cancer cases.
